Seller record · systemlabs.com

System Labs

Fails 1 of 8 criteria. S5, analytical documentation: No certificate, lot number or purity document is reachable. A testing heading lists potency, sterility, pH level and endotoxicity with no laboratory named and nothing behind it, and 221 asset URLs across the 18 pages read hold no certificate and no PDF at all.

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling sermorelin, glutathione, GHK-Cu and oxytocin beside NAD+, MIC+B12 and enclomiphene. Four of its public surfaces print four different prices for the same products, and its page data marks them as A/B variants.

Operating entity System Laboratories, Inc.

Dispositions

CodeCriterionDispositionWhere it was read
S1Prescriber requirementPASSsystemlabs.com/faqs
S2Prescription gatingPASSsystemlabs.com/intake/sermorelin
S3Pharmacy identificationPASSsystemlabs.com/faqs
S4Compounding disclosurePASSsystemlabs.com
S5Analytical documentationFAILsystemlabs.com
S6Business addressPASSsystemlabs.com/contact
S7Price disclosurePASSsystemlabs.com/treatments/all-treatments
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSA footer disclaimer on every page states that therapies are prescribed following a clinical evaluation, and the questions page states that all providers are United States based licensed physicians, nurse practitioners and physician assistants who pass a National Practitioner Databank review.Source: systemlabs.com/faqs.
S2PASSEligibility questions gate the order. The first screen after the sermorelin call to action asks why the drug is sought, and seventeen screens later the intake had asked about pituitary conditions and concurrent growth hormone secretagogues without offering a payment field.Source: systemlabs.com/intake/sermorelin.
S3PASSOne filling pharmacy is named with a street address and a telephone number, The Pharmacy Hub in Miami, Florida. The terms name the same company again as the dispensing party, and the marketing copy elsewhere says only licensed United States pharmacies.Source: systemlabs.com/faqs.
S4PASSA footer disclosure on every page states that the peptide medications offered have not been approved by the FDA, and that therapies may include medications compounded by a state-licensed pharmacy.Source: systemlabs.com.
S5FAILNo certificate, lot number or purity document is reachable. A testing heading lists potency, sterility, pH level and endotoxicity with no laboratory named and nothing behind it, and 221 asset URLs across the 18 pages read hold no certificate and no PDF at all.Source: systemlabs.com.
S6PASSThe contact page prints 564 Market Street, San Francisco, California, and the terms and the privacy statement print it again. No suite, floor or unit number accompanies it.Source: systemlabs.com/contact.
S7PASSPrices are printed on public pages before intake, from 69 dollars for a first month of NAD+ nasal spray to 109 dollars a month for GHK-Cu. Four public surfaces disagree on the figure for the same product, the page data marks the difference as an A/B variant, and two cards label a quarterly supply with a first-month price.Source: systemlabs.com/treatments/all-treatments.
S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: sermorelin injection, oral compounded sermorelin, glutathione injection, glutathione nasal spray, GHK-Cu skin topical, GHK-Cu scalp foam, oxytocin nasal spray, NAD+ injection, NAD+ nasal spray, MIC+B12, enclomiphene.

Unpaid link. System Labs does not pay the site, and nothing is earned when it is used. Funding.

Visit System Labs

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.